Hall Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$38.7M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$3.33M |
| 3 |
Apple
AAPL
|
+$1.85M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.38M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$1.04M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$806K |
| 3 |
VanEck Semiconductor ETF
SMH
|
+$762K |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$620K |
| 5 |
Johnson & Johnson
JNJ
|
+$391K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.58% |
| 2 | Consumer Staples | 8.41% |
| 3 | Financials | 8.02% |
| 4 | Healthcare | 6.9% |
| 5 | Industrials | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Colgate-Palmolive
CL
$73.1B
| $251K | 0.09% |
2,940
-405
| -12% | -$36.1K |
|
102
Dominion Energy
D
$60.8B
| $242K | 0.09% |
3,758
| – | – |
|
103
Bloom Energy
BE
$60.6B
| $235K | 0.08% |
+830
| New | +$122K |
|
104
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $221K | 0.08% |
625
| – | – |
|
105
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
| $216K | 0.08% |
1,828
+22
| +1% | +$2.57K |
|
106
Global X Defense Tech ETF
SHLD
$7.05B
| $205K | 0.07% |
+3,000
| New | +$223K |
|
107
Pfizer
PFE
$143B
| $203K | 0.07% |
+7,618
| New | +$203K |
|
108
Mastercard
MA
$502B
| – | – |
-382
| Closed | -$218K |
|
Similar funds
Hall Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Hall Capital Management held 108 positions worth $280M, up 8% from $259M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Hall Capital Management deployed $50.6M of net new capital in Q1 2026, opening 10 new positions and adding to 48 existing holdings. Its largest new stake was Bristol-Myers Squibb: 23,612 shares worth $1.43M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Staples and Financials.
On the sell side, the largest reduction was Boston Scientific, an estimated $1.04M trimmed.
- Hall Capital Management's largest Q1 2026 buy was Bristol-Myers Squibb: 23,612 shares worth $1.43M.
- Hall Capital Management added most to Vanguard Morningstar Mid-Cap ETF in Q1 2026, an estimated $38.7M increase.
- Hall Capital Management's biggest Q1 2026 reduction was Boston Scientific, cutting an estimated $1.04M.
- Hall Capital Management fully exited Mastercard in Q1 2026, selling an estimated $218K.
- Hall Capital Management's ten largest holdings make up 48% of its $280M portfolio in Q1 2026.
- Hall Capital Management opened 10 new positions and closed 1 in Q1 2026.
- Hall Capital Management's portfolio value rose 8% quarter-over-quarter to $280M.
Based on Hall Capital Management's 13F filing for Q1 2026, filed 11 May 2026.